JPS59161320A - リポ多糖体およびその製造法 - Google Patents

リポ多糖体およびその製造法

Info

Publication number
JPS59161320A
JPS59161320A JP58035621A JP3562183A JPS59161320A JP S59161320 A JPS59161320 A JP S59161320A JP 58035621 A JP58035621 A JP 58035621A JP 3562183 A JP3562183 A JP 3562183A JP S59161320 A JPS59161320 A JP S59161320A
Authority
JP
Japan
Prior art keywords
ribopolysaccharide
lipopolysaccharide
cells
tumor
surface active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58035621A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6241601B2 (cg-RX-API-DMAC7.html
Inventor
Hiroshi Obata
小畠　寛
Takahiro Suekane
末包　孝広
Kazuhiro Kumagai
熊谷　一紘
Tsukasa Ooya
大矢　宰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeria Pharmaceutical Co Ltd
Original Assignee
Zeria Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharmaceutical Co Ltd filed Critical Zeria Pharmaceutical Co Ltd
Priority to JP58035621A priority Critical patent/JPS59161320A/ja
Priority to DE19843407823 priority patent/DE3407823A1/de
Priority to FR8403415A priority patent/FR2542012B1/fr
Priority to GB08405742A priority patent/GB2137649B/en
Publication of JPS59161320A publication Critical patent/JPS59161320A/ja
Priority to US06/889,957 priority patent/US4746511A/en
Publication of JPS6241601B2 publication Critical patent/JPS6241601B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP58035621A 1983-03-04 1983-03-04 リポ多糖体およびその製造法 Granted JPS59161320A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP58035621A JPS59161320A (ja) 1983-03-04 1983-03-04 リポ多糖体およびその製造法
DE19843407823 DE3407823A1 (de) 1983-03-04 1984-03-02 Lipopolysaccharid und verfahren zu seiner herstellung
FR8403415A FR2542012B1 (fr) 1983-03-04 1984-03-02 Lipopolysaccharide et procede pour sa preparation
GB08405742A GB2137649B (en) 1983-03-04 1984-03-05 A lipopolysaccharide and a process for its preparation
US06/889,957 US4746511A (en) 1983-03-04 1986-07-28 Lipopolysaccharide and process for preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58035621A JPS59161320A (ja) 1983-03-04 1983-03-04 リポ多糖体およびその製造法

Publications (2)

Publication Number Publication Date
JPS59161320A true JPS59161320A (ja) 1984-09-12
JPS6241601B2 JPS6241601B2 (cg-RX-API-DMAC7.html) 1987-09-03

Family

ID=12446924

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58035621A Granted JPS59161320A (ja) 1983-03-04 1983-03-04 リポ多糖体およびその製造法

Country Status (5)

Country Link
US (1) US4746511A (cg-RX-API-DMAC7.html)
JP (1) JPS59161320A (cg-RX-API-DMAC7.html)
DE (1) DE3407823A1 (cg-RX-API-DMAC7.html)
FR (1) FR2542012B1 (cg-RX-API-DMAC7.html)
GB (1) GB2137649B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998039017A1 (en) * 1997-03-07 1998-09-11 Akira Hayashi Immunotherapeutic agent for cancer containing nucleoidal component of bacterium as active ingredient

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005204A1 (fr) * 1985-03-04 1986-09-12 Sawai Pharmaceutical Co., Ltd. Nouvelle substance induisant le facteur necrosique tumoral et provenant de bacteries resistantes aux acides
US4918174A (en) * 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds
US4942224A (en) * 1987-01-12 1990-07-17 The Biomembrane Institute A-associated H-antigens, monoclonal antibodies specific thereto and methods for employing the same in blood typing
US4857639A (en) * 1987-01-12 1989-08-15 The Biomembrane Institute A-associated H-antigens, monoclonal antibodies specific thereto and methods for employing the same in blood typing
KR900007498B1 (ko) * 1987-06-18 1990-10-11 구레하 가가꾸 고교 가부시끼가이샤 다당류 및 그것을 활성성분으로 함유하는 항바이러스 약제
DE3817762A1 (de) * 1988-05-26 1989-11-30 Sanum Kehlbeck Gmbh & Co Kg Immunstimulierendes mittel aus propionibakterien sowie verfahren zur herstellung desselben
US5043287A (en) * 1989-05-16 1991-08-27 The Standard Oil Company Recovery of water soluble biopolymers from an aqueous solution by employing a polyoxide
DE69014030T3 (de) * 1989-09-05 1999-06-24 Ajinomoto Co., Inc., Tokio/Tokyo Mittel für die Verhütung und Behandlung von Diarrhöe.
ES2072348T3 (es) * 1989-11-07 1995-07-16 Lepetit Spa Procedimiento de recuperacion del antibiotico a/16686.
US5918384A (en) 1993-08-17 1999-07-06 Akeva L.L.C. Athletic shoe with improved sole
WO1997010845A1 (en) * 1995-09-18 1997-03-27 Board Of Trustees Of The University Of Illinois An immunostimulant and antineoplastic glycan obtained from mycobacterium vaccae
DE19621488C2 (de) * 1996-05-29 1998-05-14 Gerlach Gerald F Prof Dr Diagnostisches Verfahren zur Erkennung subklinisch an Paratuberkulose erkrankter Säuger
CA2293821C (en) * 1997-06-10 2004-05-11 Tai Ho Chung Carbohydrate complex extracted from mycobacterium tuberculosis and process for the preparation thereof
US6015796A (en) * 1998-03-11 2000-01-18 Zeria Pharmaceutical Co., Ltd. Method for treating AIDS
US6020325A (en) * 1999-03-09 2000-02-01 Zeria Pharmaceutical Co., Ltd. Method for inhibiting replication of HIV
US6726913B1 (en) 1999-10-15 2004-04-27 The Van Kampen Group, Inc. Treatment of dermal tumors, warts, and viral infections of the respiratory tract in humans using heat-killed P. acnes
AU1201801A (en) * 1999-10-15 2001-08-07 Van Kampen Group, Inc., The Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes
WO2003009859A1 (en) * 2001-07-19 2003-02-06 Azuma, Ichiro Immunotherapy for humans
TWI297052B (cg-RX-API-DMAC7.html) * 2002-10-18 2008-05-21 Yuen Foong Yu Paper Mfg Co Ltd
ES2231037B1 (es) * 2003-10-31 2005-12-16 Archivel Technologies, Sl Agente inmunoterapico util para el tratamiento combinado de la tuberculosis en asociacion con otros farmacos.
WO2006107980A2 (en) * 2005-04-05 2006-10-12 Eco-Pets, Llc Compositions and methods to eliminate odors
CN106008735B (zh) * 2016-06-27 2019-04-30 西北农林科技大学 一种超声波协同表面活性剂提取枸杞多糖的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2403733A1 (de) * 1974-01-26 1975-08-14 Hoechst Ag Neue lipopolysaccharide und verfahren zu ihrer herstellung
JPS5428830A (en) * 1977-08-09 1979-03-03 Ichirou Azuma Immunological treating agent of tumor containing glycolipid as effective component
JPS568320A (en) * 1979-07-04 1981-01-28 Chisato Maruyama Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent
US4479935A (en) * 1980-04-22 1984-10-30 Institut Pasteur Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
US4315919A (en) * 1980-10-06 1982-02-16 Edward Shanbrom Depyrogenation process
DE3048699C2 (de) * 1980-12-23 1985-03-28 Chisato Tokio/Tokyo Maruyama Immuntherapeutisches Mittel gegen Tumore, enthaltend als wirksame Komponente ein Lipopolysaccharid

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998039017A1 (en) * 1997-03-07 1998-09-11 Akira Hayashi Immunotherapeutic agent for cancer containing nucleoidal component of bacterium as active ingredient
US6593096B1 (en) 1997-03-07 2003-07-15 Akira Hayashi Immunotherapeutic agent for cancer containing nucleoidal component of bacterium as active ingredient

Also Published As

Publication number Publication date
JPS6241601B2 (cg-RX-API-DMAC7.html) 1987-09-03
GB8405742D0 (en) 1984-04-11
US4746511A (en) 1988-05-24
GB2137649B (en) 1986-04-30
FR2542012B1 (fr) 1988-01-22
DE3407823C2 (cg-RX-API-DMAC7.html) 1989-02-02
DE3407823A1 (de) 1984-09-06
GB2137649A (en) 1984-10-10
FR2542012A1 (fr) 1984-09-07

Similar Documents

Publication Publication Date Title
JPS59161320A (ja) リポ多糖体およびその製造法
RU2511044C2 (ru) ПОЛИСАХАРИД ИЗ ШТАММА Bifidobacterium infantis И ЕГО ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРЕДУПРЕЖДЕНИЯ ВОСПАЛИТЕЛЬНЫХ РАССТРОЙСТВ.
US4329452A (en) Immunotherapeutic agent for tumors comprising lipopolysaccharide as an active component
DK172252B1 (da) Præparat til fremme af vedhæftningen af bakterier til mave-tarmkanal i mennesker og dyr samt fremgangsmåde til fremstilling af et protein med samme egenskaber
JPS59175440A (ja) グラム陰性バクテリアのワクチン
US3876779A (en) Agents effective as non-specific stimulants for antitumoral immunity derived from micro-organisms of the mycobacteria type and methods for their manufacture
CH639396A5 (fr) Substance dite ''ks-2-b'' et procede pour sa fabrication.
US4242270A (en) Process for separating lipids from endotoxins
JP2904687B2 (ja) 新規オリゴ糖
CN104873978A (zh) 一种猪瘟脾淋源活疫苗用冻干保护剂
CA2019614C (en) Antihypertensives and food and drinks
LU86195A1 (fr) Acylglycannes extraits de klebsiella,leur procede d'obtention,leur application a titre de medicaments et les compositions les renfermant
JP2855283B2 (ja) 抗潰瘍剤およびその製造法
CN104873971A (zh) 一种猪瘟脾淋源活疫苗用稀释液
CN110373356A (zh) 一种抑制产肠毒素大肠杆菌生长的解淀粉芽孢杆菌胞外多糖
JPH0572921B2 (cg-RX-API-DMAC7.html)
Smith et al. Continued Fever due to a Gärtner-like Salmonella of the Type “Dublin.”
Nitta et al. Water-soluble adjuvant obtained from Bacterionema matruchotii
JPS5839624A (ja) 抗腫瘍剤
Olitzki et al. Further investigations on the chemistry, toxicity and other biological properties of different fractions of dysentery bacteria
BE1000255A4 (fr) Procede de preparation d'une souche de bordetella bronchiseptica mutante amelioree interessante comme vaccin vivant attenue conferant une protection contre les infections par b. bronchiseptica et vaccin ra vivant attenue que l'on en obtient.
WO1984002912A1 (fr) Proteine a effet oncostatique, son procede de preparation et mediament oncostatique la contenant
Cann et al. Epidemic Dysentery in the Nursing Staff due to Bacillus dysenteriae (Sonne)
EP0890648A1 (en) Non-toxic lipopolysaccharide and its preparation
DE10115276A1 (de) Impfstoff zum Schutze von Geflügel gegen Salmonellose und ein Verfahren zur Herstellung desselben